XOEX - ETF AI Analysis
Top Page
Xtrackers S&P 100 Ex Top 20 ETF (XOEX)
XOEX has an overall rating that suggests it is a solid, but not perfect, ETF, supported by several high-quality companies with strong financial performance and growth prospects. Holdings like Merck, Lam Research, Applied Materials, and Caterpillar contribute positively through robust earnings, attractive valuations, and strategic focus on AI and industrial growth, while names such as Procter & Gamble and Chevron add stability but face bearish technical trends and valuation concerns that slightly weigh on the fund. The main risk factor is the ETF’s reliance on large, often richly valued companies where overvaluation, high debt, and sector-specific challenges could increase volatility if market conditions worsen.
XOEX vs. SPDR S&P 500 ETF (SPY)
- AUM
- 277.57M
- Region
- North America
- Expense Ratio
- 0.15%
- Beta
- 0.74
- Issuer
- Xtrackers
- Inception Date
- Nov 09, 2022
- Dividend Yield
- 1.46%
- Asset Class
- Equity
- Index Tracked
- S&P 100 Ex-Top 20 Select Index - USD - Benchmark TR Gross
XOEX Summary
XOEX is an exchange-traded fund that follows the S&P 100 Ex-Top 20 Select Index, focusing on large U.S. companies while leaving out the very largest 20 names. It spreads your money across many sectors like health care, technology, and financials. Well-known holdings include AbbVie, Mastercard, Chevron, Coca-Cola, and Home Depot. Someone might invest in XOEX to get diversified exposure to many big, established U.S. companies without being overly concentrated in the biggest tech giants. A key risk is that the fund’s value can rise or fall with the overall stock market, so you could lose money in a downturn.
How much will it cost me?
This ETF has an expense ratio of 0.15%, which means you’ll pay about $1.50 per year for every $1,000 you invest. That’s lower than the average stock ETF because it’s passively managed and simply tracks an index instead of paying managers to pick individual stocks.
What would affect this ETF?
This ETF focuses on large U.S. companies outside the biggest tech names, with major exposure to health care, technology, financials, and industrials, so it could benefit from steady economic growth, innovation in medicine and software, and strong consumer demand for brands like Coca-Cola and Procter & Gamble. On the downside, higher interest rates or a weak economy could hurt banks like Bank of America and cyclical names like Caterpillar, while regulatory changes in health care, energy, or data privacy could weigh on holdings such as UnitedHealth, Chevron, and Palantir.
XOEX Top 10 Holdings
This ETF leans heavily into U.S. large caps, with a clear tilt toward health care, tech, and financials. AbbVie and Merck have been steady engines of growth, helping to keep performance on track, while Chevron’s energy rebound adds extra fuel. On the tech side, Lam Research and Applied Materials have surged over the year but recently hit some turbulence, making them powerful yet volatile drivers. Palantir’s AI story is rising, though still choppy, and Bank of America has been lagging, acting as a mild brake on the fund’s otherwise forward momentum.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 ABBV | AbbVie | 3.36% | $9.31M | $506.08B | 25.59% | 66Neutral |
 MA | Mastercard | 3.27% | $9.07M | $534.23B | 6.55% | 75Outperform |
 CVX | Chevron | 2.99% | $8.30M | $450.93B | 46.98% | 71Outperform |
 PLTR | Palantir Technologies | 3.03% | $8.40M | $477.56B | 5.05% | 74Outperform |
 PG | Procter & Gamble | 2.46% | $6.81M | $369.06B | 4.94% | 69Neutral |
 UNH | UnitedHealth | 2.45% | $6.78M | $368.36B | 12.13% | 72Outperform |
 KO | Coca-Cola | 2.34% | $6.48M | $392.31B | 30.15% | 75Outperform |
 MRK | Merck & Company | 2.32% | $6.43M | $349.89B | 61.16% | 80Outperform |
 BAC | Bank of America | 2.18% | $6.05M | $350.84B | -4.41% | 72Outperform |
 HD | Home Depot | 2.11% | $5.84M | $317.76B | -17.33% | 66Neutral |
XOEX Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XOEX, the sentiment is Positive. The current price of 40.66 is above the 20-day moving average (MA) of 40.29, below the 50-day MA of 40.67, and above the 200-day MA of 38.71, indicating a neutral trend. The MACD of 0.07 indicates Negative momentum. The RSI at 54.81 is Neutral, neither overbought nor oversold. The STOCH value of 58.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XOEX.
XOEX Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| XOEX | $40.66 | $45.00(10.69% Upside) | $277.57M | 0.15% | 73Outperform |
 CVLC | $94.96 | $116.23(22.39% Upside) | $994.63M | 0.15% | 73Outperform |
 INFO | $28.33 | $33.91(19.70% Upside) | $952.57M | 0.35% | 74Outperform |
 AFLG | $45.00 | $53.14(18.10% Upside) | $922.53M | 0.55% | 74Outperform |
 XVV | $58.88 | $71.00(20.58% Upside) | $894.25M | 0.08% | 74Outperform |
 PTL | $273.14 | $343.59(25.79% Upside) | $878.09M | 0.09% | 70Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| XOEX | Xtrackers S&P 100 Ex Top 20 ETF | 40.66 | 5.46 | 15.51% | |
| CVLC | Calvert US Large-Cap Core Responsible Index ETF | 94.96 | 11.93 | 14.37% | |
| INFO | Harbor PanAgora Dynamic Large Cap Core ETF | 28.33 | 3.99 | 16.37% | |
| AFLG | First Trust Active Factor Large Cap ETF | 45.00 | 6.28 | 16.23% | |
| XVV | iShares ESG Screened S&P 500 ETF | 58.88 | 6.81 | 13.08% | |
| PTL | Inspire 500 ETF | 273.14 | 24.31 | 9.77% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.